| Date Filed | Type | Description |
| 08/04/2023 |
4
| Guindo Chirfi (Chief Marketing Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Exercised 36,901 shares
@ $105.7, valued at
$3.9M
Paid exercise price by delivering 17,989 shares
@ $105.7, valued at
$1.9M
Exercised 36,901 restricted stock units
@ $0 |
|
| 05/04/2023 |
4
| Guindo Chirfi (Chief Marketing Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 34,578 options to buy
@ $117.89, valued at
$4.1M
|
|
| 04/28/2023 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 08/04/2022 |
4
| Guindo Chirfi (Chief Marketing Officer) has filed a Form 4 on Merck & Co., Inc.|
Txns:
| Granted 110,705 restricted stock units
@ $0 |
|
| 07/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2022 |
4
| Guindo Chirfi (Head of Glob Prod Strat & Com) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 560 shares
@ $214.59, valued at
$120.2k
Paid exercise price by delivering 593 shares
@ $214.59, valued at
$127.3k
Paid exercise price by delivering 1,189 shares
@ $214.59, valued at
$255.1k
Exercised 1,261 restricted stock units
@ $0
Disposed of 2,395 restricted stock units
@ $0
Exercised 1,336 restricted stock units
@ $0
Disposed of 2,480 restricted stock units
@ $0 |
|
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/21/2022 |
4
| Guindo Chirfi (Head of Glob Prod Strat & Com) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 3,088 shares
@ $0 |
|
| 06/09/2021 |
4
| Guindo Chirfi (Head of Glob Prod Strat & Com) has filed a Form 4 on BIOGEN INC.|
Txns:
| Sold 3,087 shares
@ $440, valued at
$1.4M
|
|
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2020 |
4
| Guindo Chirfi (EVP Glob. Prod Strat and Comm) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 348 shares
@ $243.16, valued at
$84.6k
Paid exercise price by delivering 214 shares
@ $243.16, valued at
$52k
Exercised 481 restricted stock units
@ $0
Disposed of 693 restricted stock units
@ $0 |
|
| 02/14/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2019 |
4
| Guindo Chirfi (EVP Glob. Prod Strat and Comm) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 231 shares
@ $299.81, valued at
$69.3k
Paid exercise price by delivering 160 shares
@ $299.81, valued at
$48k
Exercised 543 restricted stock units
@ $0
Disposed of 625 restricted stock units
@ $0 |
|
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2018 |
4
| Guindo Chirfi (EVP Glob. Mkt Acc & Cust Innov) has filed a Form 4 on BIOGEN INC.|
Txns:
| Paid exercise price by delivering 231 shares
@ $333.72, valued at
$77.1k
Paid exercise price by delivering 178 shares
@ $333.72, valued at
$59.4k
Exercised 602 restricted stock units
@ $0
Disposed of 566 restricted stock units
@ $0 |
|
| 01/08/2018 |
4/A
| Guindo Chirfi (EVP Glob. Mkt Acc & Cust Innov) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 3,510 restricted stock units
@ $0 |
|
| 12/05/2017 |
4
| Guindo Chirfi (EVP Glob. Mkt Acc & Cust Innov) has filed a Form 4 on BIOGEN INC.|
Txns:
| Granted 2,350 shares
@ $0
Granted 1,755 restricted stock units
@ $0 |
|
| 11/16/2017 |
3
| Guindo Chirfi (EVP Glob. Mkt Acc & Cust Innov) has filed a Form 3 on BIOGEN INC. |